• A Multicenter Study of Outpatient Automated Blood Glucose Control with a Bihormonal Bionic Pancreas
Researchers at MGH are recruiting subjects with type 1 diabetes for a study of an experimental bionic pancreas. The bionic pancreas uses a continuous glucose monitor (CGM) and a computer program to deliver insulin or glucagon through two pumps every 5 minutes

You may be eligible if you:

• Are 18 years or older
• Live with another adult who is willing to participate as your designated contact
• Have had type 1 diabetes for at least 1 year
• Use an insulin pump (for at least the past 6 months)
• You work or study near the MGH main campus or Charlestown Navy Yard
• Live within a 30 minute drive from these locations

If you are eligible to participate, you will be trained on the use of the bionic pancreas and asked to wear the bionic pancreas for 11 days while it controls your blood sugars. You will also wear a continuous glucose monitor (CGM) for 11 days while you manage your diabetes as usual.

You will receive $50 for completing the screening visit and $1,200 for completing the study visit for a total of $1,250 compensation. Your consenting designated contact will receive $50 for completing the screening visit and $200 for completing the study for a total of $250.

For more information please contact:
Kendra Magyar, MSN PNP CDE
Phone: 617-724-6237
E-mail: klmagyar@partners.org
Institution  –  MGH - Massachusetts General Hospital, Boston, MA
Principal Investigator  – Steven J Russell, MD, PhD
Enrollment Information
For further information about enrolling a patient in this trial, contact the person below.
Name  – Kendra Magyar, MSN PNP CDE
Email  – klmagyar@partners.org
Phone  – 617-724-6237

About Type 1 Diabetes:
Type 1 diabetes accounts for 5 to 10 percent of all diagnosed cases of diabetes in the US. Type 1 diabetes usually develops in children or young adults, but can start at any age. It may also be known by a variety of other names, including the following:
  • insulin-dependent diabetes mellitus (IDDM)
  • juvenile diabetes
  • brittle diabetes
  • sugar diabetes
There are two forms of type 1 diabetes:
  • idiopathic type 1 diabetes - refers to rare forms of the disease with no known cause.
  • immune-mediated diabetes - an autoimmune disorder in which the body's immune system destroys, or attempts to destroy, the cells in the pancreas that produce insulin. Immune-mediated diabetes is the most common form of type 1 diabetes, and the one generally referred to as type 1 diabetes. The information on this page refers to this form of type 1 diabetes.